An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques.

Li, Yuanyuan; Zhang, Yanan; Zhou, Yu; Li, Yan; Xu, Jiao; Ai, Yuanbao; Xu, Lei; Xiao, Xiuli; Zhang, Bo; Jin, Jing

Li, Yuanyuan; Zhang, Yanan; Zhou, Yu; Li, Yan; Xu, Jiao; Ai, Yuanbao; Xu, Lei; Xiao, Xiuli; Zhang, Bo; Jin, Jing.

Li Y; Patronus Biotech Co. Ltd., Yantai, China. liyuanyuan@luye.com.
Zhang Y; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
Zhou Y; Patronus Biotech Co. Ltd., Yantai, China.
Li Y; Patronus Biotech Co. Ltd., Yantai, China.
Xu J; Patronus Biotech Co. Ltd., Yantai, China.
Ai Y; Patronus Biotech Co. Ltd., Yantai, China.
Xu L; Patronus Biotech Co. Ltd., Yantai, China.
Xiao X; Patronus Biotech Co. Ltd., Yantai, China.
Zhang B; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
Jin J; Patronus Biotech Co. Ltd., Yantai, China. jinjing@luye.com.

Signal Transduct Target Ther ; 8(1): 173, 2023 04 29.

Article in English | MEDLINE | ID: covidwho-2298802

Subject(s)

COVID-19; Vaccines, Virus-Like Particle; Animals; Mice; Humans; SARS-CoV-2; Macaca; COVID-19 Vaccines/therapeutic use; Antibody Formation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Virus-Like Particle / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines / Variants Limits: Animals / Humans Language: English Journal: Signal Transduct Target Ther Year: 2023 Document Type: Article Affiliation country: S41392-023-01425-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google